Skip to content

Center for Interstitial Lung Disease

Claire M. Coeshott

Claire M. Coeshott, PhD, serves as the Director of the Immunology Laboratory for National Jewish Health Advanced Diagnostic Laboratories.



Education


Education

1978 - 1982
University of Bristol, Bristol, UK, PhD, Immunology
1975 - 1978
University of Bristol, Bristol, UK, BSc Cell Pathology

Publications


Coeshott, C., Vang, B., Jones, M., and Nankervis, B. Large-scale Expansion and Characterization of CD3+ T-cells in the Quantum Cell Expansion System. J Transl Med. 2019 Aug 7;17(1):258.

Cohn, A., Morse, M.A., O'Neil, B., Whiting, S., Coeshott, C., Ferraro, J., Bellgrau, D., Apelian, D. and Rodell, T.C. Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients with Solid Tumors Bearing Ras Mutations: Results from a Phase 1 Trial. J. Immunotherapy 41: 141-150, 2018. 

Gaggar, A., Coeshott, C., Apelian, D., Rodell, T., Shen, G., Subramanian, G. M. and McHutchinson, J.G. Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study. Vaccine 32: 4925-4931, 2014. 

Stubbs, A.C., Martin, K.S., Coeshott, C., Skaates, S.V., Kuritzkes, D.R., Bellgrau, D., Franzusoff, A., Duke, R.C. and Wilson, C.C. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nature Medicine 7:625-629, 2001.  

Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S.E., Wieczorek, M. Kroona, H., Leimer, A. and Cheronis, J. Converting enzyme-independent release of TNFα and IL-1β from stimulated THP-1, a human monocytic cell line, in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. USA, 96: 6261-6266, 1999.